The new unit will be built with INEOS’ latest process technology and aims to substantially improve the sustainability of our supply to our customers and reduce our environmental impact
The launch of medical cannabis products resulted from an agreement between the two companies signed in 2021
The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
This is an exciting and meaningful milestone for GRIN Therapeutics
The summit will bring together 1,200+ delegates, 100+ international faculty from 25 countries
The trials -- ELOWEN-1 and ELOWEN-2 -- are designed to evaluate the drug in people living with lupus who experience active skin manifestations
Health innovations are viewed more positively than food and agricultural technologies
The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation
The company allocated €56 million to research and development for next-generation line solutions
Subscribe To Our Newsletter & Stay Updated
